Topics

Geron Corporation Company Profile

22:22 EST 22nd January 2020 | BioPortfolio

Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The company is advancing an anti-cancer drug and a cancer vaccine that target the enzyme telomerase through multiple clinical trials in different cancers. For more information, visit www.geron.com.


News Articles [98 Associated News Articles listed on BioPortfolio]

Geron Corporation Reports Third Quarter 2019 Financial Results and Recent Events

MENLO PARK, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the third quarter and year-to-date as of September 30, 2019 as well...

Geron Corporation Reports Second Quarter 2019 Financial Results and Recent Events

MENLO PARK, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the second quarter ended June 30, 2019, and recent events. The Company en...

Geron Begins Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes

Geron (NASDAQ:GERN) has announced it has started patient screening and enrollment of its Phase 3 clinical trials to evaluate its imetelstat drug in lower risk myelodysplastic syndromes (MDS). As quote...

Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation (Nasdaq: GERN) today reported that it has granted a non-statutory stock option to purchase an aggregate of 100,000 shares of Geron common stock as an inducement to a newly-hired emp...

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation (Nasdaq: GERN) today reported that it has granted non-statutory stock options to purchase an aggregate of 98,000 shares of Geron common stock as inducements to two newly-hired emplo...

Geron's imetelstat for adult myelofibrosis gains fast-track status

Geron's imetelstat gained the FDA's fast-track designation as a treatment for adults with high-risk or intermediate-2 myelofi -More- 

Geron Announces FDA Fast Track Designation Granted to Imetelstat for Relapsed/Refractory Myelofibrosis

MENLO PARK, Calif., Sept. 30, 2019 (GLOBE NEWSWIRE) — Geron Corporation (Nasdaq: GERN) today announced that the United States Food and Drug Administration (FDA) has granted Fast Track designatio...

1,767 Orion Corporation A shares converted into B shares

ORION CORPORATION STOCK EXCHANGE RELEASE 19 JUNE 2019 at 9.30 EEST                      1,767 Orion Corporation A shares converted into B shares In accordance wit...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [195 Associated Companies listed on BioPortfolio]

Geron Corporation

Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The ...

Genetron Health (Beijjing) Co. Ltd

As a leader in cancer precision medicine in China, Genetron is practicing the research and development concept of “exploration, discovery, application and change”. Genet...

Asterias Biotherapeutics, Inc.

Asterias Biotherapeutics is a subsidiary of BioTime, Inc., whose mission is to acquire and develop best in class cell therapy product candidates. Our first acquisition was the ste...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Geron

Geron Corporation is a biopharmaceutical company focused on discovering and developing therapeutic and diagnostic products to treat cancer and other age-related degenerative diseases. The Company is u...

More Information about "Geron Corporation" on BioPortfolio

We have published hundreds of Geron Corporation news stories on BioPortfolio along with dozens of Geron Corporation Clinical Trials and PubMed Articles about Geron Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Geron Corporation Companies in our database. You can also find out about relevant Geron Corporation Drugs and Medications on this site too.

Quick Search

Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Spinal Cord Disorders
The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine. An accident that damages the verte...


Corporate Database Quicklinks



Searches Linking to this Company Record